big news on way28 Nov 2011 19:47
Medgenics To Present at the Piper Jaffray 23rd Annual Healthcare Conference
MISGAV, Israel & SAN FRANCISCO, Nov 28, 2011 (BUSINESS WIRE) --
Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the "Company"), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that the Company will be participating in the Piper Jaffray 23rd Annual Healthcare Conference being held November 29-30, 2011 at the Palace Hotel in New York City.
On November 30th at 4:30 p.m. EST, Andrew L. Pearlman, Ph.D., Medgenics' President and Chief Executive Officer, will participate in an "unplugged" fireside chat that will include a brief overview of the Company's technology and business strategy and its progress to date. After which Piper Jaffray senior research analyst, Edward "Ted" Tenthoff, will moderate a question and answer session.
There will be a corresponding audio webcast of the presentation, which can be accessed by visiting: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=MDGN&item_id=4676398. The presentation will be archived shortly after the live event and available for 30 days following the conference. In addition, the presentation will be available for 30 days on the Investor Relations section of Medgenics website at www.medgenics.com.
In addition, Dr. Pearlman will be participating in the conference's Panel Discussion, "A Revolution in the Treatment of Hepatitis C.," moderated by Piper Jaffray senior research analyst, Edward "Ted" Tenthoff, at 10:00 a.m. EST on November 30th.
Sign In
Follow the stocks
